Regulatory

Sandoz Canada Launches Ziextenzo, Riximyo

August 19th 2020

By Skylar Jeremias

Article

After receiving regulatory approval in June, Sandoz launched 2 of its biosimilars on the Canadian market.

Fauci Discusses Experimental COVID-19 Drugs and School Openings

August 19th 2020

By Tony Hagen

Article

Monoclonal antibodies may play a frontline role in dealing with COVID-19 infections, according to Anthony S. Fauci, MD.

US May Need to Look to Germany to Reform Drug Pricing

August 19th 2020

By Skylar Jeremias

Article

US administrative and legislative efforts are moving the United States and Germany more into alignment on drug cost management philosophy, according to a review.

Winegarden: Biosimilars Market Lacks Oomph

August 17th 2020

By Tony Hagen

Article

A Pacific Research Institute economist says that by his scorecard, biosimilars are not supercharging the market the way they ought to be doing .

Irish Pharmacists Lobby for Biosimilar Substitution

August 17th 2020

By Tony Hagen

Article

Pharmacists in Ireland say the country is losing out on hundreds of millions of dollars in savings owing to the absence of a biosimilar substitution policy.

Biosimilars Gain Market Share and Advocates Get Aboard

August 15th 2020

By Skylar Jeremias

Article

There has been an outpouring of advocacy tugging biosimilars into the marketplace, and market share of these lower-cost drugs has increased.

China Approves Henlius' Biosimilar Trastuzumab

August 14th 2020

By Tony Hagen

Article

Up-and-coming Henlius Biotech consolidates its footing in the biosimilar world with another regulatory approval.

Celltrion Refutes Critique of CT-P13 Equivalence

August 14th 2020

By Deana Ferreri, PhD

Article

Celltrion finds fault with a critique of equivalence margins used to approve its infliximab biosimilar.

Pfizer Expert Urges Employers to Get Proactive on Biosimilars

August 13th 2020

By Tony Hagen

Article

Defining biosimilar use in the United States as "sluggish," Juliana Reed, MS, said employers have to get involved.

Christine Simmon and the Fight for Patent Reform

August 12th 2020

By Skylar Jeremias

Article

Opening the door to biosimilar competition starts with breaking down the patent barrier, says Christine Simmon, JD.